Literature DB >> 18805699

Insights into the mechanism of Na+,K+-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan.

Elisa S C Pôças1, Natália A Touza, Paulo H C Pimenta, Fernanda B Leitão, Chaquip D Neto, Alcides J M da Silva, Paulo R R Costa, François Noël.   

Abstract

The molecular mechanisms involved in Na+,K+-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan were investigated. We show that this compound decreases the free sulfydryl groups present in the enzyme and that its inhibitory effect is prevented by dithiothreitol and other two sulfydryl containing reagents. We propose a redox cycle culminating with the irreversible oxidation of sulfydryl groups essential for the catalytic activity of this enzyme and of two other related P-type ATPases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805699     DOI: 10.1016/j.bmc.2008.09.007

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice.

Authors:  Daniele C Rezende; Elisa S C Pôças; Humberto Muzi-Filho; Valéria M N Cunha; Afonso Caricati-Neto; Aron Jurkiewicz; François Noël; Luis E M Quintas
Journal:  J Physiol Biochem       Date:  2012-08-09       Impact factor: 4.158

2.  Ivermectin is a nonselective inhibitor of mammalian P-type ATPases.

Authors:  Paulo Henrique Cotrim Pimenta; Claudia Lucia Martins Silva; François Noël
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-30       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.